SanBio Company Ownership

SNBIF Stock  USD 3.85  0.00  0.00%   
SanBio Limited shows a total of 61.51 Million outstanding shares. SanBio Limited maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in otc stocks such as SanBio Company in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of SanBio Company, and when they decide to sell, the otc stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SanBio Company Limited. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

SanBio OTC Stock Ownership Analysis

About 36.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.59. SanBio Limited had not issued any dividends in recent years. SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company was founded in 2001 and is headquartered in Tokyo, Japan. Sanbio is traded on OTC Exchange in the United States.The quote for SanBio Company Limited is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about SanBio Company Limited contact the company at 81 3 6264 3481 or learn more at https://www.sanbio.jp.

Currently Active Assets on Macroaxis

Other Information on Investing in SanBio OTC Stock

SanBio Company financial ratios help investors to determine whether SanBio OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SanBio with respect to the benefits of owning SanBio Company security.